Chemomab Therapeutics (CMMB) Shares Issued (2018 - 2023)

Chemomab Therapeutics (CMMB) has 6 years of Shares Issued data on file, last reported at -$1.4 million in Q4 2023.

• For the quarter ending Q4 2023, Shares Issued fell 765.53% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2023 stood at -$1.1 million (down 520.6% YoY), and the FY2025 full-year result was $12000.0, down 99.88% from the prior year.
• Shares Issued for Q4 2023 stood at -$1.4 million, down from $3000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $45.4 million in Q1 2021 and bottomed at -$45.4 million in Q2 2021.
• The 5-year median for Shares Issued is $125000.0 (2020), against an average of $2.4 million.
• Peak annual rise in Shares Issued reached 7648.58% in 2021, while the deepest fall reached 36397.6% in 2021.
• A 5-year view of Shares Issued shows it stood at $30.5 million in 2019, then slumped by 98.15% to $563000.0 in 2020, then slumped by 7834.81% to -$43.5 million in 2021, then soared by 100.47% to $206000.0 in 2022, then tumbled by 765.53% to -$1.4 million in 2023.
• The last three Shares Issued figures came in at -$1.4 million (Q4 2023), $3000.0 (Q3 2023), and $206000.0 (Q4 2022), per Business Quant data.

Peer Comparison